Literature DB >> 421540

The origins of cor pulmonale; a hypothesis.

A J Block, P G Boysen, J W Wynne.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 421540     DOI： 10.1378/chest.75.2.109

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  10 in total

1.  Nocturnal hypoxemia and long-term oxygen therapy in COPD patients with daytime PaO2 60-70 mmHg.

Authors:  P Levi-Valensi; P Aubry; Z Rida
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  Development of secondary polycythaemia in chronic airways obstruction.

Authors:  J R Stradling; D J Lane
Journal:  Thorax       Date:  1981-05       Impact factor: 9.139

3.  Provision of long term oxygen therapy.

Authors:  T B Stretton
Journal:  Thorax       Date:  1985-11       Impact factor: 9.139

4.  Nocturnal oximetry in infants with cystic fibrosis.

Authors:  M P Villa; J Pagani; V Lucidi; S Palamides; R Ronchetti
Journal:  Arch Dis Child       Date:  2001-01       Impact factor: 3.791

5.  Endothelin-1 levels in interstitial lung disease patients during sleep.

Authors:  Georgia Trakada; Eugenia Nikolaou; Athanasia Pouli; Maria Tsiamita; Kostas Spiropoulos
Journal:  Sleep Breath       Date:  2003-09       Impact factor: 2.816

6.  Overnight studies in severe chronic left heart failure: arrhythmias and oxygen desaturation.

Authors:  S W Davies; L M John; J A Wedzicha; D P Lipkin
Journal:  Br Heart J       Date:  1991-02

7.  Nocturnal oxygen therapy in patients with chronic obstructive pulmonary disease: a survey of Canadian respirologists.

Authors:  Yves Lacasse; Frédéric Sériès; Sylvie Martin; François Maltais
Journal:  Can Respir J       Date:  2007-09       Impact factor: 2.409

8.  Changes in ventilation and its components in normal subjects during sleep.

Authors:  J R Stradling; G A Chadwick; A J Frew
Journal:  Thorax       Date:  1985-05       Impact factor: 9.139

9.  Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial.

Authors:  Yves Lacasse; Sarah Bernard; Frédéric Sériès; Van Hung Nguyen; Jean Bourbeau; Shawn Aaron; François Maltais
Journal:  BMC Pulm Med       Date:  2017-01-09       Impact factor: 3.317

10.  A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study.

Authors:  Sverre Lehmann; Thomas Ringbæk; Anders Løkke; Ludger Grote; Jan Hedner; Eva Lindberg
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-01-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.